Citi Pharma and China’s Xin Weisheng are establishing a fully automated antibiotic plant by 2026, producing key APIs and lifesaving antibiotics.
This step reduces import reliance and supports PPMA’s vision of self-reliance and affordable, quality medicines in Pakistan.
